Search

everythinglearnresearchcommunity

for

Search:↓

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Human epidermal neural crest stem cells can become bone and skin pigment cells, making them useful for therapies.

Targeting regulatory T cells may help treat age-related diseases.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

IL-10 may worsen alopecia areata instead of helping it.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

FFA patients have fewer melanocytes and thinner skin compared to others.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Epidermal stem cells are vital for skin healing and have potential for treating skin disorders.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Understanding sex and gender differences can improve personalized dermatology care.

A new mouse model effectively mimics vitiligo for research and drug testing.